Abstract:Objective: To systematically review the status quo, issues, and challenges from home and abroad for acupuncture research evidence, in order to identify global acupuncture research datum lines and policy-making evidence for future research direction. Method: To carry out computed searching through the Cochrane Library, MEDLINE, CNKI, SCI, WHO-ICTRP, and Chinese Clinical Trials Registry (ChiCTR) (up to January, 2010) for acupuncture-related secondary studies (systematic reviews and meta-analysis), animal randomized controlled trials (RCTs), published human RCTs (fundamental research with the human body or human body specimens as subjects), and registered on-going clinical trials (regardless of subject recruiting), and to analyze yearly publishing trends and research hotspots on subject headings for secondary studies and published and registered RCTs. Result: (1) 63.7% of acupuncture clinical RCTs were published in the Cochrane Central Register of Controlled Trials (CENTRAL), while RCTs published in MEDLINE, SCI, and CNKI each accounted for a third of all acupuncture fundamental RCTs. Publishing trends of acupuncture clinical RCTs indicated three periods – a period of slow growth before 1998, a period of gradual growth between 1999 and 2005, and a period of rapid growth after 2005. While few fundamental acupuncture RCTs were published before 2004, the period after 2005 demonstrated an increasing trend, but did not exhibit the same rapid growth as with clinical RCTs. Publication of Cochrane systematic reviews (CSRs) exhibited a time-dependent effect with acupuncture clinical RCTs, a trend that became more pronounced as time passed, while time intervals between CSR and acupuncture clinical RCT publications decreased. (2) Nine SRs were published in China, accounting for 30% of the global total of 29, while China’s 68 RCTs accounted for 21% of global RCTs. Among five CSRs affirming the effects of acupuncture, only one contained four RCTs from China, which accounted for 10% of all RCTs included in that CSR. All information provided above demonstrates a deficiency of high-quality evidence from China affirming the efficiency of acupuncture. (3) Nine CSRs published by Chinese researchers included 38 RCTs (44%) from China, as well as 48 foreign RCTs; four of these CSRs included RCTs from China only. (4) Over 70% of acupuncture fundamental RCTs were carried out by China alone while only 11% of acupuncture clinical RCTs included in SCI were from China, both of which suggest the methodology quality of acupuncture clinical RCTs in China should be raised to meet international standards. (5) Clinical research was the primary focus of acupuncture studies in Europe and the US. (6) Acupuncture studies were divided into nine research areas according to the top 50 disease-related high-frequency words in acupuncture RCTs. The first three disease categories,

Characteristics and quality of clinical practice guidelines addressing acupuncture interventions: a systematic survey of 133 guidelines and 433 acupuncture recommendations

Appraising the quality of clinical practice guidelines in traditional Chinese medicine using AGREE II instrument: A systematic review

Clinical practice guidelines of Chinese patent medicine in China: A critical review

Dissemination of Acupuncture-Moxibustion Clinical Practice Guidelines among Clinical Practitioners: A Systematic Review of Quality Assessment Studies

P044 Quality Assessment of Traditional Chinese Clinical Guidelines: 2003–2012

Using AGREE II reporting checklist to evaluate the quality of Tuina clinical practice guidelines

Quality of Critical Care Clinical Practice Guidelines: Assessment with AGREE II Instrument.

Strengthening the quality of clinical trials of acupuncture: a guideline protocol

Quality Assessment of Clinical Guidelines in China: 1993 - 2010.

Clinical Epidemiology in China Series. Paper 4: the Reporting and Methodological Quality of Chinese Clinical Practice Guidelines Published Between 2014 and 2018: A Systematic Review.

Analysis of the Status and Trends of Chinese Clinical Practice Guideline Development Between 2010 and 2020: A Systematic Review

Using AGREE II to Evaluate the Quality of Traditional Medicine Clinical Practice Guidelines in China.

The Quality of Clinical Practice Guidelines in China: a Systematic Assessment.

Quality Appraisal of Clinical Practice Guidelines for Diabetes Mellitus Published in China Between 2007 and 2017 Using the AGREE II Instrument.

Quality problems in clinical practice guidelines and guideline appraisal studies: Should we tolerate or eradicate?

Low methodological quality of systematic reviews on acupuncture: a cross-sectional study

Status Quo, Issues, and Challenges for Acupuncture Research Evidence: an Overview of Clinical and Fundamental Studies

Assessment of methodology and report quality of systematic evaluation and meta-analysis of acupuncture-moxibustion in China]

Investigation and Evaluation of Chinese Clinical Practice Guidelines Published in Medical Journals in 2019: Analysis of the Evidence

Epidemiology, Quality, and Reporting Characteristics of Systematic Reviews of Acupuncture Interventions Published in Chinese Journals

Clinical Practice Guidelines for Hypertension in China: A Systematic Review of the Methodological Quality